Southpoint Capital Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $111M | Sell |
|
|||||
|
2024
Q3 | $132M | Sell |
|
|||||
|
2024
Q2 | $238M | Buy |
|
|||||
|
2024
Q1 | $190M | Sell |
|
|||||
|
2023
Q4 | $236M | Buy |
|
|||||
|
2023
Q3 | $157M | Buy |
|
|||||
|
2023
Q2 | $84.1M | Hold |
|
|||||
|
2023
Q1 | $80.7M | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $98.4M | Buy |
|
|||||
|
2022
Q2 | $85.6M | Buy |
|